The risk of stroke is up to 2.5 times higher in racial and ethnic minorities than in the general population. That’s why we created our Minority Stroke Program to enhance community outreach efforts.
Patients with a history of intracranial hemorrhage have had few safe treatment options for nonvalvular atrial fibrillation. A new study of the Watchman device suggests that may be changing.
When Dr. Oussama Wazni takes over leadership of Cleveland Clinic’s EP section in September, he’ll be doubling down on linking research with practice to take on clinical challenges.